INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 211 filers reported holding INSMED INC in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $13,674 | -3.2% | 802 | +13.4% | 0.00% | – |
| Q4 2022 | $14,126 | -5.8% | 707 | 0.0% | 0.00% | – |
| Q3 2022 | $15,000 | +7.1% | 707 | 0.0% | 0.00% | – |
| Q2 2022 | $14,000 | -17.6% | 707 | 0.0% | 0.00% | – |
| Q1 2022 | $17,000 | -10.5% | 707 | 0.0% | 0.00% | – |
| Q4 2021 | $19,000 | 0.0% | 707 | 0.0% | 0.00% | – |
| Q3 2021 | $19,000 | -13.6% | 707 | -10.2% | 0.00% | – |
| Q2 2021 | $22,000 | -18.5% | 787 | 0.0% | 0.00% | – |
| Q1 2021 | $27,000 | +8.0% | 787 | +3.6% | 0.00% | – |
| Q4 2020 | $25,000 | – | 760 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,533,883 | $44,590,000 | 16.02% |
| Foresite Capital Management II, LLC | 919,436 | $26,728,000 | 12.07% |
| NEXTHERA CAPITAL LP | 284,263 | $8,264,000 | 10.03% |
| Palo Alto Investors LP | 7,653,617 | $222,491,000 | 9.28% |
| Asymmetry Capital Management, L.P. | 154,887 | $4,503,000 | 7.52% |
| ACUTA CAPITAL PARTNERS, LLC | 370,000 | $10,756,000 | 5.11% |
| Vivo Capital, LLC | 1,170,290 | $34,020,000 | 3.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 110,000 | $3,198,000 | 1.18% |
| Islet Management, LP | 350,000 | $10,175,000 | 1.18% |
| EMERALD ADVISERS, LLC | 921,527 | $26,789,000 | 1.09% |